Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Goldman Sachs

Does Goldman Sachs Group Stock Deserve a Place in Your Portfolio?

The shares of leading investment banking firm Goldman Sachs Group (GS) have plummeted nearly 20% in price this year amid investor fears of heightened default risk due to the war in Ukraine and U.S. regulators’ crackdown on the SPAC market. So, is GS a smart investment now? Keep reading to…

StockNews.com

Looking At Goldman Sachs Group's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bullish stance on Goldman Sachs Group. Looking at options history for Goldman Sachs Group (NYSE:GS) we detected 27 strange trades.

Benzinga

Goldman Sachs allows senior staff to take unlimited vacation

NWE YORK: Goldman Sachs Group Inc will allow senior staff to take an unlimited number of vacation days, the latest move by a Wall Street bank to retain talent in a heated job market.

The Times of India

From analysis to the latest developments in health,
read the most diverse news in one place.

Goldman Sachs offers senior staff ‘unlimited holidays’

The policy has been introduced to ‘further support time off to rest and recharge’, according to an internal memo

The Independent UK

Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2022

Upgrades

Benzinga

Goldman Sachs says senior staff can take as much holiday as they want

Junior staff not included

Wales Online

While Bitcoin, Ethereum, Dogecoin Crash — UK Crypto Platform Fetches $500M Valuation With Backing From Goldman Sachs, Barclays

United Kingdom crypto trading platform Elwood Technologies — founded by hedge fund billionaire Alan Howard — said it raised $70 million in a Series A funding round co-led by Dawn Capital and global investment bank Goldman Sachs Group Inc (NYSE: GS).

Benzinga

Read news from The Economist, FT, and more,
with one subscription

US at 'very, very high risk' of recession, says Goldman Sachs chairman Lloyd Blankfein

Goldman Sachs senior chairman Lloyd Blankfein urged companies and consumers to gird for a US recession, saying it’s a “very, very high risk.”

The Times of India

Europe’s growth forecast cut as Ukraine war drives up inflation; diesel price hits record – as it happened

Rolling coverage of the latest economic and financial news

The Guardian - UK

Michael Hiltzik: Bitcoin, NFTs, SPACs, meme stocks — all those pandemic investment darlings are crashing

The finance world, which is constantly on the lookout for rules and laws it can break in the interest of making more money, may have come up against the one law that can't be broken: the law of gravity.

Los Angeles Times

Benzinga's Top Ratings Upgrades, Downgrades For May 13, 2022

Upgrades

Benzinga

Morning Brief: Top Financial Stories Dominating on Friday, May 13

CNBC

Benzinga

Goldman Sachs Think Artists Like Beyonce Are Recession Proof - Read Why

Katie Koch, the chief investment officer for public equities at Goldman Sachs Asset Management (GSAM), quips that “Beyoncé is ultimately recession-resistant,” and so are other popular artists. That’s why the portfolios she helps oversee own shares of live-concert companies in the US and Europe.

Benzinga

HSBC pressed to spin off Asian business

HSBC Holdings Plc has begun an internal review in the face of pressure from its largest shareholder to discuss splitting off the bank's Asian operations.

Bangkok Post

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Looking Into Goldman Sachs Group's Recent Short Interest

Goldman Sachs Group's (NYSE:GS) short percent of float has fallen 15.72% since its last report. The company recently reported that it has 4.57 million shares sold short, which is 1.34% of all regular shares that are available for trading.

Benzinga

Goldman Sachs Maintains Buy Rating for Cytek Biosciences: Here's What You Need To Know

Goldman Sachs has decided to maintain its Buy rating of Cytek Biosciences (NASDAQ:CTKB) and lower its price target from $14.00 to $12.00. Shares of Cytek Biosciences are trading up 10.93% over the last 24 hours, at $8.22 per share.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2022

Bangkok Post

Goldman predicts Thai interest rate hike in Sept

Hawkish expectations in Asia’s emerging markets are piling up as traders become increasingly convinced that central banks in the region cannot ignore the threat of domestic inflation any longer.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Goldman Sachs Maintains Buy Rating for GoodRx Holdings: Here's What You Need To Know

Goldman Sachs has decided to maintain its Buy rating of GoodRx Holdings (NASDAQ:GDRX) and lower its price target from $30.00 to $12.00. Shares of GoodRx Holdings are trading up 1.32% over the last 24 hours, at $8.07 per share.

Benzinga

Check Out What Whales Are Doing With Goldman Sachs Group

A whale with a lot of money to spend has taken a noticeably bearish stance on Goldman Sachs Group. Looking at options history for Goldman Sachs Group (NYSE:GS) we detected 21 strange trades.

Benzinga

Morning Brief: Top Financial Stories Dominating on Tuesday, May 10

Reuters US Trucking Downturn Threatens Autonomous Operators like Uber Freight

Benzinga

Investors Seek Goldman Sach's Testimony On Jho Low Behind Malaysia's 1MDB Scandal: Bloomberg

Goldman Sachs Group Inc (NYSE: GS) investors are suing the bank over the 1MDB scandal and are seeking sworn testimony from three former employees who live in the U.K.

Axios

Crypto prices tank, taking some companies with them

The tumble shows what a market downdraft can do to speculative investments that don’t produce cash flows

Liverpool Echo

FSG partner latest after €1bn AC Milan takeover claims

RedBird Capital Partners - shareholders in Liverpool owners FSG - remain in the race to take over at Italian giants AC Milan

The Guardian - US

Corporate America buckles down for culture war on Roe v Wade

Republicans are mulling retaliation against firms providing benefits such as travel assistance for employees seeking abortion

1 … 81 82 83 84

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.